Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that Novartis is implementing BLI’s Beacon platform to help accelerate their antibody discovery workflow. Novartis was an early adopter of the BLI technology and the results from this early work has culminated in the […]
STEMCELL Technologies Brings Groundbreaking Intestinal and Brain Organoid Culture Tools to the Global Research Community VANCOUVER, BRITISH COLUMBIA – STEMCELL Technologies Inc. has released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the lab. Organoids, or ‘mini-organs’, are complex, 3D, in vitro culture models that maintain key structural, […]
New Partnership to Help Accelerate Translational Genomic Science Research NEW YORK, NY – BioLegend, Inc. (“BioLegend”) and the New York Genome Center (“NYGC”) announced today that they have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq™ technology for use in the research field. CITE-seq™, Cellular Indexing of Transcriptomes and Epitopes by […]
Woburn, MA: Quad Technologies, a visionary innovator in cell and gene therapy bioprocessing, today announced a strategic partnership with Sartorius Stedim Biotech, a leading provider of cutting-edge products and services for the biopharmaceutical industry. This partnership will enable worldwide availability of a magnetic bead-free T cell activation product built with Quad Technologies’ patented QuickGel® platform. […]
Highlights: • Focused R&D expansion providing core competencies in biosensor chemistries and bioassay solutions targeting pharma/biopharma applications for near and long-term portfolio expansion • Broadens cell analysis portfolio with addition of complementary plate reader-based cellular assays • Accelerates expansion into pharma/biopharma discovery and in vitro toxicology screening applications SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced […]
SEATTLE and TOKYO — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) […]
AMSBIO has introduced recombinant Wnt3a with a new Wnt stabilizer that significantly extends the activity of this protein in serum-free medium from a half-life of just 2 hours to around 30 hours. Wnt-3a is a protein that is encoded by the Wnt3a gene. The Wnt gene family consists of structurally related genes that encode secreted […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, “Atlanta Biologicals is a great fit with the Bio-Techne […]
ACEA Biosciences makes available an exhaustive library of xCELLigence papers spanning 15 years and applications ranging from immune cell killing and cell invasion/migration to viral cytopathic effect and cardiotoxicity screening SAN DIEGO In 2002 ACEA Biosciences pioneered real-time cellular impedance as a tool for dynamically tracking cell number, cell size, cell-substrate attachment strength, and cell […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
